Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients

K. Visvanathan, T. Lang, K. Ryan, R. Wilson, N. A. Skinner, A. J.V. Thompson, S. H. Ahn, F. Weilert, W. Abbott, E. Gane, D. Colledge, K. Li, S. Locarnini, A. Mansell, P. A. Revill

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients'. Together they form a unique fingerprint.

Engineering

Immunology and Microbiology

Agricultural and Biological Sciences